Almost four years following the Supreme Court’s decision to reverse Roe v. Wade, a recent study indicates a modest rise in the number of abortions across the United States. This development occurs amid ongoing legal disputes concerning the availability of the abortion medication mifepristone. Alina Salganicoff, the senior vice president and head of the KFF Women’s Health Policy Program, speaks with CBS News to provide insights on the matter.